MX358575B - Aparato y metodo para tratar el trastorno intestinal. - Google Patents

Aparato y metodo para tratar el trastorno intestinal.

Info

Publication number
MX358575B
MX358575B MX2010003937A MX2010003937A MX358575B MX 358575 B MX358575 B MX 358575B MX 2010003937 A MX2010003937 A MX 2010003937A MX 2010003937 A MX2010003937 A MX 2010003937A MX 358575 B MX358575 B MX 358575B
Authority
MX
Mexico
Prior art keywords
intestines
passage
selected part
patient
pump
Prior art date
Application number
MX2010003937A
Other languages
English (en)
Spanish (es)
Other versions
MX2010003937A (es
Inventor
Forsell Peter
Original Assignee
Implantica Patent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Implantica Patent Ltd filed Critical Implantica Patent Ltd
Publication of MX2010003937A publication Critical patent/MX2010003937A/es
Publication of MX358575B publication Critical patent/MX358575B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0507—Electrodes for the digestive system
    • A61N1/0509—Stomach and intestinal electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/045—Stomach, intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001—Means for transferring electromagnetic energy to implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1042—Alimentary tract
    • A61M2210/1064—Large intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Electrotherapy Devices (AREA)
  • Massaging Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
MX2010003937A 2007-10-12 2008-10-10 Aparato y metodo para tratar el trastorno intestinal. MX358575B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96076707P 2007-10-12 2007-10-12
PCT/SE2008/000584 WO2009048393A1 (en) 2007-10-12 2008-10-10 Apparatus and methods for treating intestinal disorder

Publications (2)

Publication Number Publication Date
MX2010003937A MX2010003937A (es) 2010-07-29
MX358575B true MX358575B (es) 2018-08-27

Family

ID=40549395

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010003937A MX358575B (es) 2007-10-12 2008-10-10 Aparato y metodo para tratar el trastorno intestinal.
MX2018010245A MX2018010245A (es) 2007-10-12 2010-04-12 Aparato y metodo para tratar el trastorno intestinal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018010245A MX2018010245A (es) 2007-10-12 2010-04-12 Aparato y metodo para tratar el trastorno intestinal.

Country Status (9)

Country Link
EP (2) EP3769718B1 (https=)
JP (7) JP2011500138A (https=)
CN (1) CN101896136B (https=)
AU (1) AU2008311446A1 (https=)
BR (2) BRPI0817873B8 (https=)
CA (1) CA2739850A1 (https=)
ES (1) ES3060592T3 (https=)
MX (2) MX358575B (https=)
WO (1) WO2009048393A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042045A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
EP3868337B1 (en) 2007-10-11 2024-07-31 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ
US8992409B2 (en) 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
WO2011128124A1 (en) * 2010-04-12 2011-10-20 Milux Holding S.A. System for treating a patient having an intestinal disorder
AU2015230810A1 (en) * 2010-04-12 2015-10-22 Implantica Patent Ltd. System for treating a patient having an intestinal disorder
EP2401985A1 (en) * 2010-07-02 2012-01-04 MyoPowers Medical Technologies SA Medical device comprising an artificial contractile structure
CN110811915B (zh) * 2013-03-15 2022-03-04 伊姆普兰蒂卡专利有限公司 约束设备
CN106510894A (zh) * 2016-10-24 2017-03-22 温州医科大学附属第医院 一种带程控可植入的治疗尿失禁的微电刺激合成吊带
JP7349154B2 (ja) * 2017-08-18 2023-09-22 イノコン メディカル エーピーエス 神経の電気刺激のためのシステム
KR102658024B1 (ko) 2021-05-07 2024-04-15 삼성에스디에스 주식회사 원통형 자재 보관 장치 및 그 장치에서 수행되는 방법
JP2024534200A (ja) * 2021-08-30 2024-09-18 インプランティカ・パテント・リミテッド 制限装置

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4222377A (en) 1977-06-27 1980-09-16 American Medical Systems, Inc. Pressure regulated artificial sphincter systems
US4634443A (en) * 1985-07-05 1987-01-06 Habley Medical Technology Corporation Single circuit elastofluidic sphincter
WO1992016162A1 (en) 1991-03-13 1992-10-01 Greater Glasgow Health Board Prosthetic anal sphincter
ATE277672T1 (de) * 1997-08-01 2004-10-15 Mann Alfred E Found Scient Res Implantierbare einrichtung mit verbesserter anordnung zur ladung der batterie und zur energiezufuhr
US6482145B1 (en) * 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
CA2639039C (en) * 2000-02-10 2011-01-25 Potencia Medical Ag Anal incontinence treatment with controlled wireless energy supply
US6166524A (en) * 2000-03-09 2000-12-26 Wilson Greatbatch Ltd. Alternate fuel gauge for an alkali metal electrochemical cell
EP1304017B1 (en) * 2000-06-30 2015-12-02 Cochlear Limited Cochlear implant
SE0102313D0 (sv) * 2001-06-28 2001-06-28 Obtech Medical Ag Intestine dysfunction treatment apparatus
US7037343B2 (en) * 2002-12-23 2006-05-02 Python, Inc. Stomach prosthesis
US7141071B2 (en) 2002-12-23 2006-11-28 Python Medical, Inc. Implantable digestive tract organ
US6752754B1 (en) 2003-02-04 2004-06-22 Imagine Enterprise, Inc. Artificial rectum and related method
US20040215283A1 (en) * 2003-04-23 2004-10-28 Antoine Camps Electrical stimulation of the colon to treat chronic constipation
JP4486345B2 (ja) * 2003-07-22 2010-06-23 トキコーポレーション株式会社 人工食道
AU2003903839A0 (en) * 2003-07-24 2003-08-07 Cochlear Limited Battery characterisation
US7835796B2 (en) * 2005-04-29 2010-11-16 Cyberonics, Inc. Weight loss method and device
SE528738C2 (sv) * 2005-06-16 2007-02-06 Sinova Safetech Innovation Ab Tarmimplantat
EP1945150A1 (en) 2005-10-14 2008-07-23 Continence Control Systems International PTY Ltd. A method and apparatus for treating fecal incontinence
JP2007135965A (ja) * 2005-11-21 2007-06-07 Tohoku Univ 体内留置多機能ステントおよびその製造方法
US20070255336A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Gastric constriction device with selectable electrode combinations
EP3868337B1 (en) * 2007-10-11 2024-07-31 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ

Also Published As

Publication number Publication date
JP7252276B2 (ja) 2023-04-04
MX2010003937A (es) 2010-07-29
BR122019007027B1 (pt) 2020-02-11
BRPI0817873A2 (pt) 2017-03-28
EP2211769B1 (en) 2020-03-04
JP2018020252A (ja) 2018-02-08
JP2023075351A (ja) 2023-05-30
CN101896136B (zh) 2013-09-18
BRPI0817873B8 (pt) 2021-06-22
JP2014223390A (ja) 2014-12-04
EP3769718A1 (en) 2021-01-27
CA2739850A1 (en) 2009-04-16
MX2018010245A (es) 2022-11-30
WO2009048393A1 (en) 2009-04-16
BRPI0817873B1 (pt) 2019-09-24
AU2008311446A1 (en) 2009-04-16
ES3060592T3 (en) 2026-03-27
JP2011500138A (ja) 2011-01-06
JP6907284B2 (ja) 2021-07-21
JP2021154166A (ja) 2021-10-07
CN101896136A (zh) 2010-11-24
JP2025143487A (ja) 2025-10-01
EP3769718C0 (en) 2025-12-31
EP2211769A1 (en) 2010-08-04
EP2211769A4 (en) 2016-03-09
EP3769718B1 (en) 2025-12-31
JP2019217410A (ja) 2019-12-26
BR122019007027B8 (pt) 2021-06-22
JP6588690B2 (ja) 2019-10-09

Similar Documents

Publication Publication Date Title
MX358575B (es) Aparato y metodo para tratar el trastorno intestinal.
CL2019000268A1 (es) Composición de cannabis.
CL2011002690A1 (es) Uso de un compuestos especificos derivados de pirimidin-2,4-diamina, inhibidores de pkc-teta para tratar un trastorno inmunologico o la aterosclerosis.
CR20120218A (es) Composición farmacéutica que comprende un agonista de glp-1, una insulina y metionina
BR102014031070A2 (pt) método de tratamento de uma formação subterrânea penetrada por um poço, e método para minimizar o sobredeslocamento de um propante a partir de uma formação subterrânea penetrada por um poço
EA201291019A1 (ru) Применение сильной сдвиговой деформации в доставке лекарственных средств
EA201590655A8 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
MX393712B (es) Uso de cannabinoides para el tratamiento de epilepsia.
CL2011000916A1 (es) Uso de una combinacion de un inhibidor de proteasoma epoxicetona peptidica o una sal farmaceutica aceptable del mismo, y uno o mas de otros agentes terapeuticos para tratar el cancer.
AR062522A1 (es) Tratamiento de desordenes en cartilagos
CO6731122A2 (es) Uso del cannabidiol fitocanabinoide (cbd) en combinación con un fármaco anti-epiléptico estandar (saed) en el tratamiento de epilepsia
CL2015000699A1 (es) Métodos para tratamiento de cáncer.
NI201500150A (es) TRATAMIENTO DE CÁNCER CON DIHIDROPIRAZINO-PIRAZINAS×Se proporcionan en la presente método
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
PH12021551540A1 (en) Anti-il-36r antibodies for treatment of palmoplantar pustulosis
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
AR093182A1 (es) Metodo para tratar el sobrepeso o la obesidad
MX387658B (es) Métodos para tratar y/o prevenir queratosis actínica.
UY33740A (es) Método para tratar el cáncer de mama y cáncer de ovarios
MX2015008190A (es) Tretaspanina 33 es una candidata para la terapia dirigida de anticuerpos para el tratamiento de linfomas de hodgkin de linfocitos b.
MX2022006812A (es) Metodos para tratar epoc mediante la administracion de un antagonista de il-33.
AR076479A1 (es) Composiciones farmaceuticas para terapias de mantenimiento que contienen como ingrediente activo un anticuerpo que reconoce el antigeno leucocitario humano (hla) de clase i
MX2018004779A (es) Uso terapeutico de una solucion oftalmica acuosa esteril.
AL et al. The molecular mechanism involved in the protective effect of etodolac against ovarian injury induced with ischemia/reperfusion in rats

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: IMPLANTICA PATENT LTD.

FG Grant or registration